Acalabrutinib for treating relapsed or refractory mantle cell lymphoma [ID6389]

  • Awaiting development
  • GID-TA11470
  • Expected publication date: TBC

NIHRIO BN: 10813-Acalabrutinib-for-Mantle-cell-lymphoma-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)